spectralmd, inc.

spectralmd, inc. has 2 AI-enabled medical devices on the FDA list. The first decision was on August 17, 2017 and the most recent on May 21, 2026 (DeepView AI® System). Its most common review panel is General and Plastic Surgery (1 device).